Back
Accenture PLC Vs. Denali Therapeutics Industry Stock Comparison
Sell
47
ACN
Accenture PLC
Last Price:
355.43
Seasonality Move:
6.03%
Buy
68
DNLI
Denali Therapeutics
Last Price:
31.31
Seasonality Move:
6.34%
Sell
47
Accenture PLC (ACN)
is a Sell
Is Accenture PLC a Buy, Sell or Hold?
- The current Accenture PLC [ACN] share price is $355.53. The Score for ACN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- ACN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $31.35. The Score for DNLI is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACN Stock Price Chart
What is Accenture PLC's stock price today?
-
The Accenture PLC share price today is $355.53
The current trend is relatively stagnant and ACN is experiencing selling pressure, which indicates risk of future bearish movement.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $31.35
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.63 | Sell |
Relative Strength Index (14 RSI): | 49.4 | Sell |
Chaikin Money Flow: | -2042062 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (351.18 - 370.04) | Sell |
Bollinger Bands (100): | (314.29 - 356.85) | Buy |
DNLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.53 | Buy |
Relative Strength Index (14 RSI): | 68.76 | Buy |
Chaikin Money Flow: | 648733 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.03 - 28.61) | Buy |
Bollinger Bands (100): | (22.45 - 28.23) | Buy |
ACN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 349.85 | Buy |
20-day SMA: | 360.49 | Sell |
50-day SMA: | 352.93 | Buy |
200-day SMA: | 335.17 | Buy |
8-day EMA: | 354.3 | Buy |
20-day EMA: | 356.14 | Sell |
50-day EMA: | 351.01 | Buy |
200-day EMA: | 334.26 | Buy |
DNLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.16 | Buy |
20-day SMA: | 27.44 | Buy |
50-day SMA: | 27.75 | Buy |
200-day SMA: | 22.07 | Buy |
8-day EMA: | 28.79 | Buy |
20-day EMA: | 27.93 | Buy |
50-day EMA: | 27.13 | Buy |
200-day EMA: | 23.94 | Buy |
Accenture PLC Earnings Growth & ACN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.90 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.87 per share, and an increase next year of $0.05 per share.
Accenture PLC Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Denali Therapeutics Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |